Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0184
0.00 (0.00%)
Jul 30, 2026, 4:00 PM EST

Nu-Med Plus Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-0.04-0.05-0.06-0.12-0.18-0.84
Net Income
-0.05-0.06-0.07-0.13-0.13-0.83
Earnings Per Share
-0.00-0.00-0.00-0.00-0.00-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0000.010.070.01
Total Debt
0.220.210.10.10.10.01
Net Cash (Debt)
-0.22-0.21-0.1-0.09-0.030
Net Cash Growth
------97.98%
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.000.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.05-0.05-0-0.07-0.04-0.21
Capital Expenditures
------
Free Cash Flow
-0.05-0.05-0-0.07-0.04-0.21
Free Cash Flow Growth
------